Lu-177-PSMA Infusion vs Injection: No Difference in Dose Rates of Patients at the Time of Outpatient Discharge

被引：0
|
作者：
Reijonen, V. [1 ]
Kiviluoto, K. [1 ,2 ]
Ahtiainen, V. [1 ]
机构：
[1] Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland
[2] Helsinki Univ Hosp, HUS Pharm, Helsinki, Finland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0790
引用
收藏
页码：S745 / S745
页数：1
相关论文
共 50 条
  • [1] Lu-177-PSMA dosimetry based on two-imaging-time-point
    Chen, Gefei
    Lu, Zhonglin
    Jiang, Han
    Afshar-Oromieh, Ali
    Rominger, Axel
    Shi, Kuangyu
    Mok, Greta
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [2] Reproducibility of SPECT-based MTV for patients treated with Lu-177-PSMA
    Nuttens, V.
    Ooms, D.
    Vermeulen, S.
    De Bondt, P.
    Koole, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S209 - S209
  • [3] Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points
    Chen, Gefei
    Lu, Zhonglin
    Jiang, Han
    Afshar-Oromieh, Ali
    Rominger, Axel
    Shi, Kuangyu
    Mok, Greta S. P.
    FRONTIERS IN MEDICINE, 2023, 10
  • [4] Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT
    Grob, Dagmar
    Prive, Bastiaan M.
    Muselaers, Constantijn H. J.
    Mehra, Niven
    Nagarajah, James
    Konijnenberg, Mark W.
    Peters, Steffie M. B.
    EJNMMI PHYSICS, 2024, 11 (01)
  • [5] Difference in Response to 177Lu-PSMA-617 Therapy in Patients with Predominantly Soft Tissue vs Osseous Metastases
    Akinlusi, Rahman
    Abdelrahman, Ahmed
    Cengiz, Turgut Bora
    Kulkarni, Raksha
    Novello, Matteo
    Goel, Reema
    Hafez, Anthony
    Gavane, Somali
    Ghesani, Munir
    Ghesani, Nasrin
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [6] Comparison of External Radiation Dose Rates Measured from 177Lu-Octreatate/Octreotide, 177Lu-PSMA and 131I Treated Patients
    Rantala, I.
    Hyypia, J.
    Paasonen, T.
    Malkonen, K.
    Eskola, M.
    Ladev, M.
    Malkonen, J.
    Kahkonen, T.
    Maenpaa, H.
    Reijonen, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S739 - S740
  • [7] Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT
    Dagmar Grob
    Bastiaan M. Privé
    Constantijn H. J. Muselaers
    Niven Mehra
    James Nagarajah
    Mark W. Konijnenberg
    Steffie M. B. Peters
    EJNMMI Physics, 11
  • [8] Induction and repair of DNA double strand breaks in blood leukocytes of prostate cancer patients during Lu-177-PSMA therapy
    Schumann, Sarah
    Scherthan, Harry
    Lapa, Constantin
    Serfling, Sebastian
    Muhtadi, Razan
    Lassmann, Michael
    Eberlein, Uta
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [9] Clinical dosimetry in [177Lu]Lu-PSMA therapy: kidney mean absorbed dose difference between subsequent cycles
    Owers, E.
    Rijkhorst, E.
    Dotinga, M.
    de Wit-van der Veen, L. J.
    de Vries-Huizing, D. M. V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S368 - S368
  • [10] Are there differences in the DNA double -strand break induction in blood leukocytes of prostate cancer patients during Ga-68-PSMA diagnostics and Lu-177-PSMA therapy?
    Schumann, Sarah
    Scherthan, Harry
    Lapa, Constantin
    Lassmann, Michael
    Eberlein, Uta
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
12345